Correlation Between Medincell and Gensight Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medincell and Gensight Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medincell and Gensight Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medincell SA and Gensight Biologics SA, you can compare the effects of market volatilities on Medincell and Gensight Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medincell with a short position of Gensight Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medincell and Gensight Biologics.

Diversification Opportunities for Medincell and Gensight Biologics

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Medincell and Gensight is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Medincell SA and Gensight Biologics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gensight Biologics and Medincell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medincell SA are associated (or correlated) with Gensight Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gensight Biologics has no effect on the direction of Medincell i.e., Medincell and Gensight Biologics go up and down completely randomly.

Pair Corralation between Medincell and Gensight Biologics

Assuming the 90 days trading horizon Medincell is expected to generate 1.16 times less return on investment than Gensight Biologics. But when comparing it to its historical volatility, Medincell SA is 1.94 times less risky than Gensight Biologics. It trades about 0.05 of its potential returns per unit of risk. Gensight Biologics SA is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  36.00  in Gensight Biologics SA on September 1, 2024 and sell it today you would earn a total of  1.00  from holding Gensight Biologics SA or generate 2.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Medincell SA  vs.  Gensight Biologics SA

 Performance 
       Timeline  
Medincell SA 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Medincell SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Medincell is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Gensight Biologics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Gensight Biologics SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Gensight Biologics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Medincell and Gensight Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medincell and Gensight Biologics

The main advantage of trading using opposite Medincell and Gensight Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medincell position performs unexpectedly, Gensight Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gensight Biologics will offset losses from the drop in Gensight Biologics' long position.
The idea behind Medincell SA and Gensight Biologics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency